Knocking out KRAS (the most common gene mutation in 95% PDA patients) in cancer cells even made insulin lose the ability to promote cancer cell viability, and insulin even turned to induced tumor cell dormancy in vitro experiments (Rajbhandari et al., 2017). The gene discussed is INS; the disease is Patent ductus arteriosus.